A new meta-analysis of randomized controlled trials showed that vitamin D supplementation significantly reduces high-sensitivity C-reactive protein.
High-sensitivity C-reactive protein (hs-CRP) is a protein that is produced in the liver. Hs-CRP is a marker of inflammation and higher levels indicate that there is inflammation present in the body.
It is well-known that vitamin D plays an important role in reducing inflammation and may help reduce the risk of inflammatory conditions such as cardiovascular disease and tuberculosis. This has led researchers to consider whether vitamin D plays a beneficial role in the inflammatory aspects of these conditions by affecting hs-CRP levels.